SCHEMBL2269138

SCHEMBL2269138

O=C(Nc1cc(Oc2ccc(Cl)c(Cl)c2)ccc1C(=O)O)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.57
KMO O15229 1/20 0.57
PYGL P06737 2/20 0.56
PYGM P11217 2/20 0.56
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
PKM P14618 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
MAPT P10636 2/20 0.55
GRIK1 P39086 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
HDAC1 Q13547 2/20 0.54
HDAC8 Q9BY41 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
ACLY P53396 1/20 0.50
HPSE Q9Y251 1/20 0.50
ALDH1A1 P00352 2/20 0.49
LMNA P02545 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2273564 0.90 HDAC1 (0.61) SERPINE1MEN1KMT2APKMNPSR1
SCHEMBL2270410 0.89 SERPINE1 (0.57) SERPINE1PYGLPYGMMEN1KMT2A
SCHEMBL2294521 0.89 SERPINE1 (0.66) SERPINE1MEN1KMT2APKMMAPT
SCHEMBL2272347 0.88 SERPINE1 (0.69) SERPINE1PYGLPYGMMEN1KMT2A
SCHEMBL2271588 0.88 SERPINE1 (0.64) SERPINE1PYGLPYGMMEN1KMT2A
SCHEMBL2273110 0.87 SERPINE1 (0.60) SERPINE1PYGLPYGMMEN1KMT2A
SCHEMBL2270449 0.86 PYGM (0.56) SERPINE1PYGLPYGMMEN1KMT2A
SCHEMBL2274838 0.86 SERPINE1 (0.66) SERPINE1PYGLPYGMMEN1KMT2A
SCHEMBL2271528 0.86 PYGM (0.61) SERPINE1PYGLPYGMMEN1KMT2A
SCHEMBL5145423 0.85 PYGM (0.61) SERPINE1PYGLPYGMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 SERPINE1 101/4885KMO 194/4885PYGL 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.